Correlation Between Keros Therapeutics and Larimar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Keros Therapeutics and Larimar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Keros Therapeutics and Larimar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Keros Therapeutics and Larimar Therapeutics, you can compare the effects of market volatilities on Keros Therapeutics and Larimar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Keros Therapeutics with a short position of Larimar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Keros Therapeutics and Larimar Therapeutics.
Diversification Opportunities for Keros Therapeutics and Larimar Therapeutics
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Keros and Larimar is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Keros Therapeutics and Larimar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Larimar Therapeutics and Keros Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Keros Therapeutics are associated (or correlated) with Larimar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Larimar Therapeutics has no effect on the direction of Keros Therapeutics i.e., Keros Therapeutics and Larimar Therapeutics go up and down completely randomly.
Pair Corralation between Keros Therapeutics and Larimar Therapeutics
Given the investment horizon of 90 days Keros Therapeutics is expected to generate 0.77 times more return on investment than Larimar Therapeutics. However, Keros Therapeutics is 1.31 times less risky than Larimar Therapeutics. It trades about -0.15 of its potential returns per unit of risk. Larimar Therapeutics is currently generating about -0.15 per unit of risk. If you would invest 1,564 in Keros Therapeutics on December 28, 2024 and sell it today you would lose (485.00) from holding Keros Therapeutics or give up 31.01% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Keros Therapeutics vs. Larimar Therapeutics
Performance |
Timeline |
Keros Therapeutics |
Larimar Therapeutics |
Keros Therapeutics and Larimar Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Keros Therapeutics and Larimar Therapeutics
The main advantage of trading using opposite Keros Therapeutics and Larimar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Keros Therapeutics position performs unexpectedly, Larimar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Larimar Therapeutics will offset losses from the drop in Larimar Therapeutics' long position.Keros Therapeutics vs. Day One Biopharmaceuticals | Keros Therapeutics vs. Mirum Pharmaceuticals | Keros Therapeutics vs. Rocket Pharmaceuticals | Keros Therapeutics vs. Avidity Biosciences |
Larimar Therapeutics vs. Day One Biopharmaceuticals | Larimar Therapeutics vs. Mirum Pharmaceuticals | Larimar Therapeutics vs. Rocket Pharmaceuticals | Larimar Therapeutics vs. Avidity Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |